Whiteoak Capital Pharma And Healthcare Fund Overview
Category Pharma Fund
BMSMONEY Rank N/A
BMSMONEY Rating N/A
Gro. Opt. As On: 22-11-2024
NAV ₹12.96(R) +1.29% ₹13.14(D) +1.29%
Returns 1Y 3Y 5Y 7Y 10Y
LumpSum (R) -% -% -% -% -%
LumpSum (D) -% -% -% -% -%
SIP (R) -% -% -% -% -%
SIP (D) -% -% -% -% -%
Ratio Sharpe Ratio Sortino Ratio Sterling Ratio Jensen's Alpha Treynor Ratio
Risk STD. Dev VaR 1Y95% Max DD Beta Semi Devi.
Top Pharma Fund
Fund Name Rank Rating
Icici Prudential Pharma Healthcare And Diagnostics (P.H.D) Fund -
Sbi Healthcare Opportunities Fund -
Tata India Pharma & Healthcare Fund -
- -
Uti Healthcare Fund -

NAV Date: 22-11-2024

Scheme Name NAV Rupee Change Percent Change
WhiteOak Capital Pharma and Heathcare Fund Regular Plan Growth 12.96
0.1700
1.2900%
WhiteOak Capital Pharma and Heathcare Fund Direct Plan Growth 13.14
0.1700
1.2900%

Review Date: 22-11-2024

A review of the different performance parameters of the fund is as follows:
  1. Returns: It reflects the surge in the investment's value throughout the investment period, communicated as a percentage or a specific monetary sum. Our analysis encompassed three return parameters of this fund. We have organized the return parameters into three performance groups for evaluation: the top 25%, parameters that rank below the top 25% but above average, and parameters that are below average. Below, you'll find a breakdown of how each parameter has performed.
    1. Top 25%: Three return parameters of the Whiteoak Capital Pharma And Healthcare Fund are in the top 25% in the category, as shown below:
      • 1M Return %
      • 3M Return %
      • 6M Return %
    2. Above Average Below the Top 25%: The fund does not have any return parameter which is above average but below the top 25%.
    3. Below Average: Whiteoak Capital Pharma And Healthcare Fund has no return parameters that are below average in the category.
  2. Risk: It is defined as the prospect of not attaining expected yields or enduring financial setbacks due to numerous causes. For Whiteoak Capital Pharma And Healthcare Fund, we have analyzed zero risk parameters and divided them into three groups the lowest 25%, below average but above the lowest 25%, and above average, which are described below.
    1. Lowest 25%: Whiteoak Capital Pharma And Healthcare Fund does not have any risk parameters in the lowest 25% of the category. It means high risk compared to other funds in the category.
    2. Below Average but Above the Lowest 25%: Whiteoak Capital Pharma And Healthcare Fund does not have any risk parameters in the below average but above the lowest 25% of the category.
    3. Above Average: Whiteoak Capital Pharma And Healthcare Fund does not have any risk parameters above average; which is a good sign.
  3. Risk Adjusted Performance Parameters: Risk-adjusted performance parameters in mutual funds are parameters that assess the return on investments based on the risks involved. These parameters provide a platform for investors to compare various investments, by considering both profits and the risks involved. For Whiteoak Capital Pharma And Healthcare Fund, we have evaluated zero risk-adjusted performance parameters.
    1. Top 25% Risk Adjusted Performance Parameters: The fund does not have any risk-adjusted performance parameters that are in the top 25% of the category.
    2. Above Average Below Top 25% Risk Adjusted Performance Parameters: The fund does not have any risk-adjusted performance parameters that are in the above average but below top 25% of the category.
    3. Below Average Risk Adjusted Performance Parameters: The fund does not have any risk-adjusted performance parameters that are in the above average but below top 25% of the category.


Not able to see in mobile!!! save the chart by clicking on camera icon.

KPIs* Fund Benchmark Cat. Avg Min | Max Rank (In Cat.) Performance
1M Return % 1.97
-0.30
-2.98 | 1.97 1 | 12 Very Good
3M Return % 6.09
1.18
-8.00 | 6.09 1 | 12 Very Good
6M Return % 27.00
19.33
10.65 | 27.00 1 | 12 Very Good
Return data last Updated On : Nov. 22, 2024.
Other parameters, fund ranking, non return related analysis are updated after every month end. Last Updated On : Oct. 31, 2024
KPIs: Key Performance Indicators

Rotate the phone! Best viewed in landscape mode on mobile.
KPIs* Fund Benchmark Cat. Avg Min | Max Rank (In Cat.) Performance
1M Return % 2.11 -0.19 -2.85 | 2.11 1 | 12
3M Return % 6.54 1.51 -7.62 | 6.54 1 | 12
6M Return % 28.10 20.11 11.58 | 28.10 1 | 12
Return data last Updated On : Nov. 22, 2024.
Other parameters, fund ranking, non return related analysis are updated after every month end. Last Updated On : Oct. 31, 2024
KPIs: Key Performance Indicators

Investment Period Regular Direct
Return % Current Value of ₹ 10000 Return % Current Value of ₹ 10000
1D 1.29 ₹ 10,129.00 1.29 ₹ 10,129.00
1W 1.58 ₹ 10,158.00 1.62 ₹ 10,162.00
1M 1.97 ₹ 10,197.00 2.11 ₹ 10,211.00
3M 6.09 ₹ 10,609.00 6.54 ₹ 10,654.00
6M 27.00 ₹ 12,700.00 28.10 ₹ 12,810.00
1Y ₹ ₹
3Y ₹ ₹
5Y ₹ ₹
7Y ₹ ₹
10Y ₹ ₹
15Y ₹ ₹

Disclaimer: Past performance may or may not be sustained in future and should not be used as a basis for comparison with other investments. Returns for periods above 1 year are annualised.

Investment Period Invested Amount Regular Direct
XIRR % Current Value of Invested Amount XIRR % Current Value of Invested Amount
1Y ₹ 12000 ₹ ₹
3Y ₹ 36000 ₹ ₹
5Y ₹ 60000 ₹ ₹
7Y ₹ 84000 ₹ ₹
10Y ₹ 120000 ₹ ₹
15Y ₹ 180000 ₹ ₹


Date Whiteoak Capital Pharma And Healthcare Fund NAV Regular Growth Whiteoak Capital Pharma And Healthcare Fund NAV Direct Growth
22-11-2024 12.958 13.142
21-11-2024 12.793 12.974
19-11-2024 12.737 12.916
18-11-2024 12.64 12.817
14-11-2024 12.757 12.933
13-11-2024 12.66 12.834
12-11-2024 12.921 13.098
11-11-2024 12.966 13.144
08-11-2024 13.167 13.346
07-11-2024 13.183 13.361
06-11-2024 13.305 13.484
05-11-2024 13.159 13.336
04-11-2024 13.12 13.296
31-10-2024 13.113 13.285
30-10-2024 12.871 13.04
29-10-2024 12.819 12.986
28-10-2024 12.833 13.0
25-10-2024 12.679 12.842
24-10-2024 12.711 12.874
23-10-2024 12.636 12.798
22-10-2024 12.708 12.87

Fund Launch Date: 06/Feb/2024
Fund Category: Pharma Fund
Investment Objective: To provide long-term capital appreciation by investing predominantly in equity and equity related instruments of Pharma and Healthcare companies. There is no assurance that the investment objective of the Scheme will be achieved.
Fund Description: An open ended equity scheme investing in Pharma and Healthcare sector
Fund Benchmark: BSE Healthcare Total Return Index
Source: Fund FactSheet

Disclaimer: NO INVESTMENT ADVICE. The Content is for informational purposes only.